EcoR1 Capital, LLC

Average Profitability
31.34%
Insider Buys Quantity
29
Insider Buys Sum
$242.59M
Insider Sells Quantity
6
Insider Sells Sum
$63.04M

Insider Activity of EcoR1 Capital, LLC

According to the SEC Form 4 filings, EcoR1 Capital, LLC, being in a position of

  1. 10 percent owner at AnaptysBio, Inc.,
    оver the last 12 months, has bought 273972 shares for $10M, and sold 0 shares,
    over all time since 2021-02-23, has bought 3981072 shares for $82M, and sold 0 shares.

The largest purchase of all time was on 2021-03-08 and amounted to 2777800 shares of AnaptysBio, Inc. for $52.69M.

The largest sale of all time was on 2022-05-05 and amounted to 1062736 shares of Prothena Corporation plc for $30.84M.

Biography of EcoR1 Capital, LLC

No biography is available at this moment.

2024-08-14PurchaseAnaptysBio, Inc.
ANAB
10 percent owner
273,972
1.095%
$36.50$10M0%
2023-06-16PurchaseZymeworks Inc.
ZYME
10 percent owner
3.35M
5.0195%
$8.12$27.2M+7.27%
2023-03-28PurchaseZymeworks Inc.
ZYME
10 percent owner
200,000
0.2981%
$8.00$1.6M+6.44%
2023-01-20PurchaseZymeworks Inc.
ZYME
director
163,400
0.2428%
$9.88$1.62M-16.45%
2023-01-19PurchaseZymeworks Inc.
ZYME
director
144,100
0.2124%
$9.49$1.37M-13.66%
2023-01-18PurchaseZymeworks Inc.
ZYME
director
203,000
0.3051%
$10.00$2.03M-16.43%
2023-01-17PurchaseZymeworks Inc.
ZYME
director
440,000
0.6486%
$9.80$4.31M-16.43%
2023-01-13PurchaseZymeworks Inc.
ZYME
director
342,100
0.5024%
$9.81$3.35M-16.78%
2023-01-11SaleVoyager Therapeutics, Inc.
VYGR
director
110,000
0.2722%
$8.50$934,615-9.72%
2023-01-11PurchaseZymeworks Inc.
ZYME
director
106,300
0.1527%
$7.87$836,911+1.43%
2023-01-10SaleVoyager Therapeutics, Inc.
VYGR
director
336,400
0.8885%
$8.05$2.71M+1.82%
2023-01-10PurchaseZymeworks Inc.
ZYME
director
920,000
1.3565%
$7.65$7.04M+7.02%
2023-01-09SaleVoyager Therapeutics, Inc.
VYGR
director
456,000
1.3029%
$7.67$3.5M+15.43%
2022-06-21PurchaseVoyager Therapeutics, Inc.
VYGR
376,000
1.0477%
$5.66$2.13M+28.87%
2022-05-05SaleProthena Corporation plc
PRTA
1.06M
2.2706%
$29.02$30.84M+77.02%
2022-05-05PurchaseProthena Corporation plc
PRTA
1.06M
2.2706%
$29.02$30.84M+77.02%
2022-01-12PurchaseProthena Corporation plc
PRTA
10 percent owner
300,000
0.6429%
$37.50$11.25M-9.98%
2021-10-01SaleCorvus Pharmaceuticals, Inc.
CRVS
10 percent owner
2M
4.4342%
$4.96$9.93M-67.36%
2021-09-30SaleCorvus Pharmaceuticals, Inc.
CRVS
10 percent owner
3M
6.7156%
$5.04$15.13M-67.46%
2021-05-04PurchaseAnaptysBio, Inc.
ANAB
165,000
0.5959%
$23.25$3.84M+12.89%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.